Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Subscriber?
Search

August 2025

What’s Behind the Surge in Laboratory Outreach Sales?

TDR Insider /

The recent CHS-Labcorp deal is one of many that highlights a market shift. Clinical lab outreach services, once viewed as strategic assets, are being sold off rapidly as hospitals recenter around core services and offload logistical burdens. This year, 30% of lab mergers and acquisitions involve outreach agreements, with national lab companies seeing opportunities to […]

To access this post, you must purchase The Dark Report.

What’s Behind the Surge in Laboratory Outreach Sales? Read More »

An Insider’s Observances of Lab Outreach Deals

Commentary and Opinion by R. Lewis Dark /

THERE ARE MANY WAYS TO VIEW CLINICAL LABORATORY OUTREACH ACQUISITIONS and the enormous amount of money changing hands in these deals. From one point of view, those fearful of the continued expansion of national lab giants like Labcorp and Quest Diagnostics may shiver every time one of these companies grabs a new outreach site. Meanwhile,

To access this post, you must purchase The Dark Report.

An Insider’s Observances of Lab Outreach Deals Read More »

What’s Behind the Surge in Lab Outreach Sales?

Clinical Laboratory Trends /

CEO SUMMARY: The recent CHS-Labcorp deal is one of many that highlights a market shift. Clinical lab outreach services, once viewed as strategic assets, are being sold off rapidly as hospitals recenter around core services and offload logistical burdens. This year, 30% of lab mergers and acquisitions involve outreach agreements, with national lab companies seeing

To access this post, you must purchase The Dark Report.

What’s Behind the Surge in Lab Outreach Sales? Read More »

Profitable Collaboration with Pharma Companies

Laboratory Management /

CEO SUMMARY: Drug discovery efforts by pharmaceutical companies often need a boost from anatomic pathology practices and clinical laboratories. Forward-thinking lab leaders and pathologists can take advantage of their data and expertise to partner with pharma, setting the stage for new revenue streams. CLINICAL AND PATHOLOGY LABORATORIES COULD OPEN NEW REVENUE STREAMS through partnerships with

To access this post, you must purchase The Dark Report.

Profitable Collaboration with Pharma Companies Read More »

Former Payer CEO Posts Sharp Comments on LinkedIn

Clinical Laboratory Trends /

FORMER CEO OF PUBLICLY-TRADED INSURANCE COMPANY MOLINA HEALTHCARE, J. Mario Molina, MD, took to LinkedIn in July offering a sobering perspective on the current state of the private payer industry. Drawing on his 14 years at the helm, Molina remarked, “What’s happening right now does not surprise me. Things don’t happen in isolation.” His unsettling

To access this post, you must purchase The Dark Report.

Former Payer CEO Posts Sharp Comments on LinkedIn Read More »

Despite Trade Tariffs, IVD Firms Report Upbeat Earnings

In Vitro Diagnostics /

LEADING IN VITRO DIAGNOSTICS (IVD) COMPANIES RECENTLY REPORTED POSITIVE QUARTERLY FINANCIALS despite swirling concerns about trade tariffs and cuts to US federal research grants. It’s not yet clear what the long-term effect of tariffs’ will be on IVD manufacturers, assuming the trade fees remain in effect. Generally, executives are acknowledging the pressure but do not

To access this post, you must purchase The Dark Report.

Despite Trade Tariffs, IVD Firms Report Upbeat Earnings Read More »

How Federal Court’s Decision Will Affect Lab Marketing

Laboratory Compliance /

MOST MEDICAL PROVIDERS are buyers of healthcare services. But for clinical laboratories, that equation is turned on its head. Labs are medical providers, but since they rarely provide those services directly to patients, they must properly market them to providers to ensure steady sales. The enactment of the Eliminating Kickbacks in Recovery Act of 2018

To access this post, you must purchase The Dark Report.

How Federal Court’s Decision Will Affect Lab Marketing Read More »

My Green Lab Prepares Full-Scale Entry into Diagnostics

Clinical Laboratory /

AGAINST THE BACKDROP OF REDUCED SUSTAINABILITY INITIATIVES IN THE CORPORATE AND POLITICAL WORLDS, environmental stewardship remained a topic of discussion  at the Association for Diagnostics and Laboratory Medicine’s (ADLM) 2025 conference. Among the more interesting announcements was that Siemens Healthineers became the first company to complete a pilot clinical lab certification for sustainability via My

To access this post, you must purchase The Dark Report.

My Green Lab Prepares Full-Scale Entry into Diagnostics Read More »

August 25, 2025, Intelligence: Late-Breaking Lab News

Late Breaking Lab News /

As we first reported in Dark Daily earlier this month, several states have taken initiative to regulate how artificial intelligence (AI) applies to clinical laboratory services. For example, a California law that went into effect earlier this year impacts providers who use generative AI to create patient communications about clinical information. Those providers must now

To access this post, you must purchase The Dark Report.

August 25, 2025, Intelligence: Late-Breaking Lab News Read More »

Clinical Labs Battle Complex Claims Denials

Laboratory Billing /

CEO SUMMARY: While the number of denials is not going up, the reasons that private payers deny claims are becoming more complex and time-consuming to appeal. After reviewing noteworthy trends among payers, learn a three-level approach to appeals that may lead to greater success and speed up the process. AS PAYERS ADOPT NEW STRATEGIES IN

To access this post, you must purchase The Dark Report.

Clinical Labs Battle Complex Claims Denials Read More »

;